移植診断の世界市場:技術、製品・サービス(装置、試薬、ソフトウェア)、用途、エンドユーザー

◆英語タイトル:Transplant Diagnostics Market by Technology (SSO-PCR, SSP-PCR, NGS, Sanger’s Sequencing), Products & Services (Instruments, Reagents, Software), Application (Diagnostics, Research), End User (Hospitals, Academia, Diagnostic Center) - Forecast to 2021
◆商品コード:MAM-MD-3686
◆発行会社(調査会社):MarketsandMarkets
◆発行日:2016年5月6日
◆ページ数:184
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD5,650 ⇒換算¥644,100見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥758,100見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥929,100見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規販売代理店です。MarketsandMarkets社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、移植診断の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、バリューチェーン分析、市場シェア分析、市場環境分析、技術別分析、製品別分析、用途別分析、エンドユーザー別分析、市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。
【レポートの概要】

The global transplant diagnostics market is projected to reach USD 753.9 Million by 2021 from USD 535.0 Million in 2016, growing at a CAGR of 7.1% from 2016 to 2021. Market growth can be attributed to factors such as the rising number of solid organ, soft tissue, and stem cell transplantations; technological advancements in the field of organ transplantations; and increased funding, research grants, and public-private investments. However, the high device costs associated with NGS and PCR-based devices and limited medical reimbursements for organ donation and transplantation procedures restrain the optimal growth of the market.
On the basis of products and services, the transplant diagnostics market is segmented into reagents and consumables, instruments, and software & services. The reagents and consumables segment is expected to account for the largest share of the global market in 2016. Reagents and consumables are the fastest-growing product segment, growing at a double-digit CAGR during 2016 to 2021. Market growth of the reagents and consumables segment is propelled by factors such as long-term sales contracts signed by market players with major end users, expanding applications of molecular assay techniques in HLA typing, increasing marker preference for HLA typing in organ transplantation, rising number of organ transplantation procedures across major markets (such as the U.S., Germany, the U.K., Japan, China, and India), and growing utilization of HLA typing in research. The instruments segment is expected to hold the second-largest share of the global transplant diagnostics market in 2016. The dominant market position of the transplant diagnostic instruments segment is mainly due to factors such as ongoing technological advancements in the field of HLA typing (such as device automation and commercialization of NGS instruments), increasing awareness regarding the benefits of genome-based HLA typing as compared to serological assays, and increasing adoption of PCR and NGS instruments among CROs, transplant centers, and hospitals.

On the basis of applications, the global transplant diagnostics market is segmented into diagnostic and research applications. The diagnostic applications segment is expected to account for the larger share of the global market in 2016. The diagnostic applications segment is also projected to grow faster as compared to research applications in the global market during 2016–2021. The significant growth potential of the diagnostic applications segment can be attributed to factors such as the rising number of solid organ transplantations, increasing installation base of PCR & sequencing-based devices, growing adoption of HLA profiling among hospitals and transplant centers, and rising awareness among public related to the benefits of molecular assay-based procedures. The research applications segment is expected to witness a positive market growth during the study period due to factors such as increasing public private investments that support genomics-based transplantation research, growing use of robotics in laboratory automation, and growing number of PCR and NGS-based clinical trials.

Geographically, the transplant diagnostics market is classified into four regions North America, Europe, Asia-Pacific, and the Rest of the World. North America and Europe are mature markets for transplant diagnostic products. However, emerging regions such as Asia-Pacific (including Japan, China, and India, among others) are expected to become new revenue-generating pockets in the transplant diagnostics market in the next five years. The North American market is expected to hold the largest share of the global market in 2016; it is projected to grow at the highest CAGR during the forecast period owing to easy accessibility and high adoption of advanced diagnostic technologies (such as PCR and NGS) among healthcare professionals, increasing prevalence of target diseases (such as cancer, heart failure, and renal diseases) in the U.S. and Canada, and continuous technological advancements in the field of transplant diagnostics.

Product development & commercialization and agreements, collaborations, and partnerships were the key growth strategies adopted by prominent players to strengthen their global positioning in the transplant diagnostics market. Moreover, strategies such as mergers, acquisitions, and geographic expansions were also adopted by a significant number of market players to strengthen their product portfolios and expand their distribution networks in the global market during 2012–2015.

As of 2015, the key players in the transplant diagnostics market included Thermo Fischer Scientific, Inc. (U.S.), Immucor, Inc. (U.S), Olerup SSp AB (Sweden), QIAGEN, Inc. (Netherlands), Bio-Rad Laboratories, Inc. (U.S.), Affymetrix, Inc. (U.S.), Illumina Inc. (U.S.), Luminex Corporation, (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), and Abbott Laboratories, Inc. (U.S.), among others.

【レポートの目次】

1 Introduction (Page No. – 16)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
1.3.3 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Introduction (Page No. – 20)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Breakdown of Primaries
2.2 Opportunity Indicators
2.2.1 Introduction
2.2.2 Demand-Side Analysis
2.2.2.1 Healthcare Expenditure Patterns
2.2.2.2 Rapid Growth in Geriatric Population
2.2.2.3 Rising Incidence and Prevalence of Cancer
2.2.2.4 Growing Burden of Cardiovascular Diseases (CVDs)
2.2.2.5 Increasing Number of Organ Donations and Transplantations
2.2.3 Supply-Side Analysis
2.2.3.1 Number of New Product Launches: Transplant Diagnostics vs. Competitive Technologies
2.2.3.2 Parent Market Analysis: Immunoassay Market
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Market Breakdown and Data Triangulation
2.5 Research Assumptions
2.5.1 Assumptions

3 Executive Summary (Page No. – 41)
3.1 Introduction
3.2 Current Scenario
3.3 Future Outlook
3.4 Conclusion

4 Premium Insights (Page No. – 48)
4.1 Global Transplant Diagnostics Market Overview
4.2 Global Transplant Diagnostics Technology Market, By Region (2016)
4.3 Global Transplant Diagnostics Product and Services Market, By Region (2016-2021)
4.4 Global Transplant Diagnostics Applications Market, By Region (2016-2021)
4.5 Global Transplant Diagnostics Market, By End User (2016–2021)
4.6 Global Transplant Diagnostics Market, By Country (2016–2021)

5 Market Overview (Page No. – 53)
5.1 Introduction
5.2 Market Segmentation
5.3 Market Dynamics
5.3.1 Key Market Drivers
5.3.1.1 Growing Number of Solid Organ, Soft-Tissue, and Stem Cell Transplantation Procedures
5.3.1.2 Technological Advancements in the Field of Hla Typing
5.3.1.3 Increased Funding, Research Grants, and Public-Private Investments
5.3.2 Key Market Restraints
5.3.2.1 High Cost of NGS and PCR-Based Devices
5.3.2.2 Limited Medical Reimbursements for Organ Donation and Transplantation Procedures
5.3.3 Key Market Opportunities
5.3.3.1 Technological Shift From Serological Assays to Gene-Based Hla Profiling
5.3.3.2 Improving Healthcare Infrastructure Across Developing Countries
5.3.4 Key Market Challenges
5.3.4.1 Significant Gap Between Number of Organs Donated and Organs Required Annually

6 Industry Insights (Page No. – 63)
6.1 Introduction
6.2 Value Chain Analysis
6.3 Industry Trends
6.3.1 Integration of Advanced Technologies With Molecular Assay Procedure
6.4 Porter’s Five Forces Analysis
6.4.1 Threat of New Entrants
6.4.2 Threat of Substitutes
6.4.3 Bargaining Power of Suppliers
6.4.4 Bargaining Power of Buyers
6.4.5 Intensity of Competitive Rivalry

7 Transplant Diagnostics Market, By Technology (Page No. – 69)
7.1 Introduction
7.2 Molecular Assays
7.2.1 PCR-Based Molecular Assays
7.2.1.1 Sequence-Specific Primer (SSP)-PCR
7.2.1.2 Sequence-Specific Oligonucleotide (SSO)-PCR
7.2.2 Sequencing-Based Molecular Assays
7.2.2.1 Sanger Sequencing
7.2.2.2 Next-Generation Sequencing (NGS)
7.3 Non-Molecular Assays
7.3.1 Serological Assays
7.3.2 Mixed Lymphocyte Culture (MLC) Assays

8 Transplant Diagnostics Market, By Products & Services (Page No. – 82)
8.1 Introduction
8.2 Reagents and Consumables
8.3 Instruments
8.4 Software and Services

9 Transplant Diagnostics Market, By Application (Page No. – 87)
9.1 Introduction
9.2 Diagnostic Applications
9.3 Research Applications

10 Transplant Diagnostics Market, By End User (Page No. – 92)
10.1 Introduction
10.2 Hospitals and Transplant Centers
10.3 Commercial Service Providers
10.4 Research Laboratories and Academic Institutes

11 Transplant Diagnostics Market, By Region (Page No. – 98)
11.1 Introduction
11.2 North America
11.2.1 U.S.
11.2.2 Canada
11.3 Europe
11.3.1 Germany
11.3.2 U.K.
11.3.3 France
11.3.4 Rest of Europe (RoE)
11.4 Asia-Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Rest of Asia-Pacific (RoAPAC)
11.5 Rest of the World (RoW)

12 Competitive Landscape (Page No. – 128)
12.1 Overview
12.2 Market Share Analysis
12.3 Competitive Scenario
12.4 Recent Developments
12.4.1 Agreements, Partnerships, and Collaborations
12.4.2 New Product Launches, Approvals, and Product Enhancements
12.4.3 Strategic Acquisitions
12.4.4 Geographic Expansions

13 Company Profiles (Page No. – 136)
13.1 Introduction
13.1.1 Geographic Benchmarking
13.1.2 Strategic Benchmarking
13.1.2.1 Capacity Building and Capability Enhancement
13.2 Thermo Fisher Scientific, Inc.
13.2.1 Business Overview
13.2.2 Products Offered
13.2.3 Recent Developments
13.2.4 MnM View
13.3 Immucor, Inc.
13.3.1 Business Overview
13.3.2 Products Offered
13.3.3 Recent Developments
13.3.4 MnM View
13.4 Olerup SSP AB
13.4.1 Business Overview
13.4.2 Products Offered
13.4.3 Recent Developments
13.4.4 MnM View
13.5 Qiagen N.V.
13.5.1 Business Overview
13.5.2 Products Offered
13.5.3 Recent Developments
13.5.4 MnM View
13.6 Bio-Rad Laboratories, Inc.
13.6.1 Business Overview
13.6.2 Products Offered
13.6.3 Recent Developments
13.6.4 MnM View
13.7 Illumina, Inc.
13.7.1 Business Overview
13.7.2 Products Offered
13.7.3 Recent Developments
13.8 Affymetrix, Inc.
13.8.1 Business Overview
13.8.2 Products Offered
13.8.3 Recent Developments
13.9 F. Hoffmann-La-Roche Limited
13.9.1 Business Overview
13.9.2 Products Offered
13.9.3 Recent Developments
13.10 Luminex Corporation
13.10.1 Business Overview
13.10.2 Products Offered
13.10.3 Recent Developments
13.11 Abbott Laboratories, Inc.
13.11.1 Business Overview
13.11.2 Products Offered
13.11.3 Recent Developments

14 Appendix (Page No. – 171)
14.1 Insights of Industry Experts
14.2 Discussion Guide
14.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
14.4 Introducing RT: Real-Time Market Intelligence
14.5 Available Customizations
14.6 Related Reports

List of Tables (79 Tables)

Table 1 Total Cost of Transplant Procedures in the U.S., By Organ (Including Transplant Diagnosis and Monitoring)
Table 2 Global Transplant Diagnostics Market Size, By Technology, 2014-2021 (USD Million)
Table 3 Global Market Size for Molecular Assays, By Type, 2014-2021 (USD Million)
Table 4 Market Size for Molecular Assays, By Region, 2014-2021 (USD Million)
Table 5 Global Market Size for PCR-Based Molecular Assays, By Type, 2014-2021 (USD Million)
Table 6 Market Size for PCR-Based Molecular Assays, By Region, 2014-2021 (USD Million)
Table 7 Market Size for SSP-PCR-Based Molecular Assays, By Region, 2014-2021 (USD Million)
Table 8 Market Size for SSO-PCR-Based Molecular Assays, By Region, 2014-2021 (USD Million)
Table 9 Global Market Size for Sequencing-Based Molecular Assays, By Type, 2014-2021 (USD Million)
Table 10 Market Size for Sequencing-Based Molecular Assays, By Region, 2014-2021 (USD Million)
Table 11 Market Size for Sanger Sequencing, By Region, 2014-2021 (USD Million)
Table 12 Market Size for NGS, By Region, 2014-2021 (USD Million)
Table 13 Market Size for Non-Molecular Assays, By Type, 2014-2021 (USD Million)
Table 14 Market Size for Non-Molecular Assays, By Region, 2014-2021 (USD Million)
Table 15 Market Size for Serological Assays, By Region, 2014-2021 (USD Million)
Table 16 Market Size for MLC Assays, By Region, 2014-2021 (USD Million)
Table 17 Global Market Size, By Products & Services, 2014-2021 (USD Million)
Table 18 Transplant Diagnostic Reagents and Consumables Market Size, By Region, 2014-2021 (USD Million)
Table 19 Transplant Diagnostic Instruments Market Size, By Region, 2014-2021 (USD Million)
Table 20 Transplant Diagnostic Software and Services Market Size, By Region, 2014-2021 (USD Million)
Table 21 Global Market Size, By Application, 2014-2021 (USD Million)
Table 22 Market Size for Diagnostic Applications, By Region, 2014-2021 (USD Million)
Table 23 Market Size for Research Applications, By Region, 2014-2021 (USD Million)
Table 24 Global Market Size, By End User, 2014–2021 (USD Million)
Table 25 Market Size for Hospitals and Transplant Centers, By Region, 2014–2021 (USD Million)
Table 26 Market Size for Commercial Service Providers, By Region, 2014–2021 (USD Million)
Table 27 Market Size for Research Laboratories and Academic Institutes, By Region, 2014–2021 (USD Million)
Table 28 Market Size, By Region, 2014-2021 (USD Million)
Table 29 North America: Market Size, By Country, 2014-2021
Table 30 U.S.: Market Size, By Technology, 2014-2021 (USD Million)
Table 31 U.S.: Market Size, By Products & Services, 2014-2021 (USD Million)
Table 32 U.S.: Market Size, By Application, 2014-2021 (USD Million)
Table 33 U.S.: Market Size, By End User, 2014-2021 (USD Million)
Table 34 Canada: Market Size, By Technology, 2014-2021 (USD Million)
Table 35 Canada: Market Size, By Products & Services, 2014-2021 (USD Million)
Table 36 Canada: Market Size, By Application, 2014-2021 (USD Million)
Table 37 Canada: Market Size, By End User, 2014-2021 (USD Million)
Table 38 Europe: Market Size, By Country, 2014-2021 (USD Million)
Table 39 Germany: Market Size, By Technology, 2014-2021 (USD Million)
Table 40 Germany: Market Size, By Products & Services, 2014-2021 (USD Million)
Table 41 Germany: Market Size, By Application, 2014-2021 (USD Million)
Table 42 Germany: Market Size, By End User, 2014-2021
Table 43 U.K.: Market Size, By Technology, 2014-2021 (USD Million)
Table 44 U.K.: Market Size, By Products & Services, 2014-2021 (USD Million)
Table 45 U.K.: Market Size, By Application, 2014-2021 (USD Million)
Table 46 U.K.: Market Size, By End User, 2014-2021 (USD Million)
Table 47 France: Market Size, By Technology, 2014-2021 (USD Million)
Table 48 France: Market Size, By Products & Services, 2014-2021 (USD Million)
Table 49 France: Market Size, By Application, 2014-2021 (USD Million)
Table 50 France: Market Size, By End User, 2014-2021 (USD Million)
Table 51 RoE: Market Size, By Technology, 2014-2021 (USD Million)
Table 52 RoE: Market Size, By Products & Services, 2014-2021 (USD Million)
Table 53 RoE: Market Size, By Application, 2014-2021 (USD Million)
Table 54 RoE: Transplant Diagnostics Market Size, By End User, 2014-2021 (USD Million)
Table 55 Asia-Pacific: Transplant Diagnostics Market Size, By Country, 2014-2021 (USD Million)
Table 56 Japan: Transplant Diagnostics Market Size, By Technology, 2014-2021 (USD Million)
Table 57 Japan: Transplant Diagnostics Market Size, By Products & Services, 2014-2021 (USD Million)
Table 58 Japan: Transplant Diagnostics Market Size, By Application, 2014-2021 (USD Million)
Table 59 Japan: Transplant Diagnostics Market Size, By End User, 2014-2021 (USD Million)
Table 60 China: Transplant Diagnostics Market Size, By Technology, 2014-2021 (USD Million)
Table 61 China: Transplant Diagnostics Market Size, By Products & Services, 2014-2021 (USD Million)
Table 62 China: Transplant Diagnostics Market Size, By Application, 2014-2021 (USD Million)
Table 63 China: Transplant Diagnostics Market Size, By End User, 2014-2021 (USD Million)
Table 64 India: Transplant Diagnostics Market Size, By Technology, 2014-2021 (USD Million)
Table 65 India: Transplant Diagnostics Market Size, By Products & Services, 2014-2021 (USD Million)
Table 66 India: Transplant Diagnostics Market Size, By Application, 2014-2021 (USD Million)
Table 67 India: Transplant Diagnostics Market Size, By End User, 2014-2021 (USD Million)
Table 68 RoAPAC: Transplant Diagnostics Market Size, By Technology, 2014-2021 (USD Million)
Table 69 RoAPAC: Transplant Diagnostics Market Size, By Products & Services, 2014-2021 (USD Million)
Table 70 RoAPAC: Transplant Diagnostics Market Size, By Application, 2014-2021 (USD Million)
Table 71 RoAPAC: Transplant Diagnostics Market Size, By End User, 2014-2021 (USD Million)
Table 72 RoW: Transplant Diagnostics Market Size, By Technology, 2014-2021 (USD Million)
Table 73 RoW: Transplant Diagnostics Market Size, By Products & Services, 2014-2021 (USD Million)
Table 74 RoW: Transplant Diagnostics Market Size, By Application, 2014-2021 (USD Million)
Table 75 RoW: Transplant Diagnostics Market Size, By End User, 2014-2021 (USD Million)
Table 76 Top Agreements, Partnerships, and Collaborations, 2012–2016
Table 77 Top New Product Launches, Approvals, and Product Enhancements, 2012–2016
Table 78 Top Strategic Acquisitions, 2012–2016
Table 79 Top Geographical Expansions, 2012–2016

List of Figures (60 Figures)

Figure 1 Research Design
Figure 2 Healthcare Expenditure Across Major Countries: 2000–2013
Figure 3 Healthcare Expenditure Across Major Regions: 2000–2013
Figure 4 Healthcare Spending Matrix: Key Markets (2013)
Figure 5 Increase in Geriatric Population, By Country (2011–2030)
Figure 6 Increase in the Proportion of the Elderly in the Overall Population, By Country (2011–2030)
Figure 7 Percentage Increase in Geriatric Population, By Region (1980–2010 vs. 2010–2040)
Figure 8 Global Burden of Cancer, By Region (2005–2030)
Figure 9 Number of New Cancer Cases, By Country (2012–2020)
Figure 10 Increasing Incidence of Various Cancers, 2008–2020
Figure 11 Global Burden of Cardiovascular Diseases, By Region (2005–2030)
Figure 12 Number of Living and Deceased Organ Donations, By Country (2010–2014)
Figure 13 Number of New Product Launches: Transplant Diagnostic Assay vs. Competitive Modalities, 2012–2015
Figure 14 Molecular Assay-Based Transplant Diagnostic Technology is Expected to Be the Fastest-Growing Immunoassay Technology By 2021
Figure 15 Bottom-Up Approach: Transplant Diagnostics Instruments Market
Figure 16 Bottom-Up Approach: Transplant Diagnostic Reagents and Consumables Market
Figure 17 Top-Down Approach
Figure 18 Data Triangulation
Figure 19 Assumptions of the Research Study
Figure 20 Global Transplant Diagnostics Market Size, By Technology, 2016 vs. 2021
Figure 21 Geographic Analysis: Transplant Diagnostics Market, By Products & Services, 2016
Figure 22 Geographic Analysis: Transplant Diagnostics Market Size, By Application, 2016 vs. 2021
Figure 23 Global Transplant Diagnostics Market Size, By End User, 2016 vs. 2021
Figure 24 Transplant Diagnostics Market Share, By Region, 2016
Figure 25 Growing Number of Transplantation Procedures to Drive the Market Growth for Transplant Diagnostics
Figure 26 North America is Expected to Dominate the Transplant Diagnostics Market, By Technology, in 2016
Figure 27 Reagents and Consumables to Dominate the Transplant Diagnostics Products Market During the Forecast Period
Figure 28 North America is Expected to Command the Largest Share of Transplant Diagnostics Applications Market in 2016
Figure 29 Hospitals and Transplant Centers to Dominate the Transplant Diagnostics Market in the Forecast Period
Figure 30 U.S. and Germany are Expected to Dominate the Global Transplant Diagnostics Market Till 2021
Figure 31 Transplant Diagnostics Market: Drivers, Restraints, Opportunities, and Challenges
Figure 32 Number of Organ Transplant Procedures, 2010–2013
Figure 33 Percentage Change in Annual Healthcare Expenditure—Developed vs. Developing Countries (2010–2013)
Figure 34 Value Chain Analysis: Major Value is Added to the Overall Product Pricing During R&D Phase
Figure 35 Porter’s Five Forces Analysis: Transplant Diagnostics Market (2015)
Figure 36 Growing Adoption of PCR- and NGS-Based Products is Propelling Revenue Growth for Molecular Assays Market
Figure 37 NGS-Based Devices are Expected to Form the Fastest-Growing Molecular Assay Technology Segment Till 2021
Figure 38 Serological Assay Technique is Expected to Witness Positive Market Growth During 2016-2021
Figure 39 Reagents and Consumables Segment to Dominate the Transplant Diagnostics Market During the Forecast Period (2016–2021)
Figure 40 Diagnostic Applications Segment to Dominate the Market During the Forecast Period
Figure 41 The Hospitals & Transplant Centers End-User Segment is Expected to Dominate the Transplant Diagnostics Market in 2016
Figure 42 U.S. and Germany to Grow at the Highest Rates in the Transplant Diagnostics Market
Figure 43 North American Transplant Diagnostics Market Snapshot: 2016-2021
Figure 44 European Transplant Diagnostics Market Snapshot: 2016-2021
Figure 45 Asia-Pacific Transplant Diagnostics Market Snapshot: 2016-2021
Figure 46 RoW Transplant Diagnostics Market Snapshot: 2016-2021
Figure 47 Agreements, Partnerships, and Collaborations: Key Growth Strategy Adopted By A Majority of Market Players From 2012 to 2016
Figure 48 Global Transplant Diagnostics Market Share, Key Player, 2015
Figure 49 Growing Number of Agreements, Partnerships, and Collaborations is Stimulating Market Competition Among Key Products Manufacturers
Figure 50 Geographic Revenue Mix of the Top 5 Market Players* (2015)
Figure 51 Capacity Building and Capability Enhancement: A Key Growth Strategy Adopted By Major Market Players
Figure 52 Thermo Fisher Scientific, Inc.: Company Snapshot
Figure 53 Immucor, Inc.: Company Snapshot
Figure 54 Qiagen N.V.: Company Snapshot
Figure 55 Bio-Rad Laboratories, Inc.: Company Snapshot
Figure 56 Illumina, Inc.: Company Snapshot
Figure 57 Affymetrix, Inc.: Company Snapshot
Figure 58 F. Hoffmann-La-Roche Ltd: Company Snapshot
Figure 59 Luminex Corporation: Company Snapshot
Figure 60 Abbott Laboratories, Inc.: Company Snapshot

【レポートのキーワード】

移植診断、移植検査、技術、製品、サービス、移植診断装置、移植診断試薬、ソフトウェア、用途、エンドユーザー、分子検査、PCRベース診断、SSO-PCR、SSP-PCR、次世代シークエンシング法、非分子検査、血清検査、リンパ球混合培養検査(MLC検査)

★調査レポート[移植診断の世界市場:技術、製品・サービス(装置、試薬、ソフトウェア)、用途、エンドユーザー]販売に関する免責事項
★調査レポート[移植診断の世界市場:技術、製品・サービス(装置、試薬、ソフトウェア)、用途、エンドユーザー]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆